ZURA Zura Bio Limited
Healthcare$4.21-3.44%ClosedMarket Cap: $273.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.26
P/S
0.00
EV/EBITDA
-0.71
DCF Value
$1.16
FCF Yield
-25.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-54.6%
ROA
-33.0%
ROIC
-37.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-25.5M | $-24.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-18.4M | $-17.2M | $— | — |
| FY null | $0.00 | NaN% | $-75.2M | $-68.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-19.5M | $-18.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-18.1M | $-16.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-19.3M | $-17.4M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-15.7M | $-9.0M | $— | — |
| FY null | $0.00 | NaN% | $-55.2M | $-52.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-19.3M | $-20.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-11.8M | $-10.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-8.4M | $-7.7M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-10.8M | $-8.5M | $-0.18 | — |